Technical Analysis for JNCE - Jounce Therapeutics, Inc.

Grade Last Price % Change Price Change
grade F 3.38 -0.88% -0.03
JNCE closed down 0.88 percent on Friday, September 20, 2019, on approximately normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Earnings due: Sep 27

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical JNCE trend table...

Date Alert Name Type % Chg
MACD Bearish Signal Line Cross Bearish 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
Oversold Stochastic Weakness 0.00%
Bollinger Band Squeeze Range Contraction -0.88%
Bollinger Band Squeeze Range Contraction -1.46%
Stochastic Reached Oversold Weakness -1.46%
Oversold Stochastic Weakness -1.46%
Bollinger Band Squeeze Range Contraction -0.88%
Doji - Bullish? Reversal -0.88%
BB Squeeze + Lower Band Touch Range Contraction -0.88%

Older signals for JNCE ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Jounce Therapeutics, Inc. is a clinical-stage immunotherapy company. It engaged in developing therapies which enable the immune system to attack tumors. The Company's lead product candidate, JTX-2011, is a clinical-stage monoclonal antibody that binds to and activates the Inducible T cell CO-Stimulator, a protein on the surface of certain T cells found in a range of solid tumors. It also developing JTX-4014 for use in future combinations with JTX-2011, as well as for use in combination with other future product candidates. Jounce Therapeutics, Inc. is based in Cambridge, United States.
Biotechnology Life Sciences Biology Natural Sciences Immunology Solid Tumors Immunotherapy Immune System Monoclonal Antibodies
Is JNCE a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 7.35
52 Week Low 2.66
Average Volume 187,687
200-Day Moving Average 4.6339
50-Day Moving Average 3.984
20-Day Moving Average 3.5835
10-Day Moving Average 3.554
Average True Range 0.2256
ADX 21.26
+DI 14.1626
-DI 23.6835
Chandelier Exit (Long, 3 ATRs ) 3.3711
Chandelier Exit (Short, 3 ATRs ) 3.9868
Upper Bollinger Band 3.8781
Lower Bollinger Band 3.2889
Percent B (%b) 0.15
BandWidth 16.442026
MACD Line -0.1605
MACD Signal Line -0.1599
MACD Histogram -0.0006
Fundamentals Value
Market Cap 108.68 Million
Num Shares 32.2 Million
EPS 0.03
Price-to-Earnings (P/E) Ratio 112.67
Price-to-Sales 5.66
Price-to-Book 2.51
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.56
Resistance 3 (R3) 3.57 3.51 3.53
Resistance 2 (R2) 3.51 3.47 3.51 3.52
Resistance 1 (R1) 3.45 3.44 3.42 3.44 3.51
Pivot Point 3.39 3.39 3.38 3.39 3.39
Support 1 (S1) 3.33 3.35 3.30 3.32 3.25
Support 2 (S2) 3.27 3.32 3.27 3.24
Support 3 (S3) 3.21 3.27 3.23
Support 4 (S4) 3.20